Stelara Approved in US to Treat Moderate-to-Severe Ulcerative Colitis
News
The U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) for the treatment of adults with ulcerative colitis (UC) that is moderately to severely active, Janssen Pharmaceuticals, Stelara’s developer and ... Read more